Research & Stock Picks

Emiten Report

31 July 2023

By

Digital acquisition to boost efficiency

Digital acquisition to boost efficiency

BMRI results came above our expectations and cons. BMRI posted 2Q23 earnings of IDR 12.7tn (+0.9% QoQ, +24.5% YoY), translating to 6M23 earnings of IDR 25.2tn (+24.9% YoY), beating our and street estimates (SSI: 54.1%, cons: 53.5%). Provision expense came in at IDR 3.9tn in 2Q23 (+6.6% QoQ, +10.6% YoY), bringing its 6M23 figure to IDR 7.6tn (+2.1% YoY), implying a credit cost of ~1.19%, lower than the bank’s previous guidance (1.3%-1.5%). In addition to lower provision expense, further improvement in CIR ratio (36.8% in 1H23) was a major contributor to BMRI’s good results, with a chunk of it coming from lower other allowances costs and promotion expenses. The bank’s NII came in at IDR 24.3tn in 2Q23 (+5.6% QoQ, +13.8% YoY), translating into 6M23 NII of IDR 47.3tn (+13.1% YoY). Regarding loans, BMRI distributed IDR 1,267tn worth of loans in 1H23 (+5.6% QoQ, +11.3% YoY), with high-yielding segments, especially commercial segment, as the main driver, in line with the bank’s strategy. BMRI also reported positive growth in deposits, which was recorded at IDR 1,430tn in 2Q23 (+2.8% QoQ, +8.5% YoY).

 

Main focus going forward. Going into 2H23, we believe the bank’s CIR to normalize to ~39% in FY23F, though BMRI’s management remains confident that the bank will book a CIR of 36% in the long term, supported by digital acquisitions, which are expected to boost efficiency. It is worth highlighting that tightening liquidity will be the main challenge for the banking sector in 2H23; however, BMRI’s management remains positive that it could achieve its FY23 NIM target of 5.3%-5.6% despite limited room to re-price its loan yield in 2H23, as the bank will continue to focus on disbursing loan to high yield segments such as commercial and SME segments. Even with tighter liquidity, we believe the pressure on CoF will be manageable as the Livin app has continued to gain more popularity, and it will help the bank to increase its CASA ratio further. It is worth noting that 80% of BMRI’s customer CASA accounts are now linked to Livin.

 

2023F guidance During the analyst meeting, BMRI stated that it maintains its loan growth guidance at 10%-12%, and expects CoC to decline to 1.1%-1.3% in 2023F, compared to the previous guidance of 1.3%-1.5%, as BMRI already has an adequate coverage level and better asset quality management risk compared to other banks, and BMRI hinted that it expects its CoC to reach 1.0%-1.2% next year. Lastly, BMRI remains optimistic that its NIM could be in the range of 5.3%-5.6% this year and remain there next year.

BUY, TP of IDR 6,600/share. We reiterate our BUY rating on BMRI with a 12-month TP of IDR 6,600/share, implying a 2023F PBV of 2.5x. Downside risks: worse-than-expected economic recovery, lower-than-expected NIM and loan growth, and higher cost of credit

Share This:

Download PDF

Download PDF

English
Indonesian

Download PDF

English
Indonesian

More Related

Daily Stock Technical Recommendations

May 21, 2024

Daily Report

May 20, 2024

Daily Stock Technical Recommendations

May 20, 2024

Daily Stock Technical Recommendations

May 17, 2024

Daily Report

May 17, 2024

Daily Stock Technical Recommendations

May 16, 2024

Daily Report

May 16, 2024

Daily Report

May 15, 2024

Daily Stock Technical Recommendations

May 15, 2024

Daily Report

May 15, 2024

Daily Report

May 14, 2024

Daily Stock Technical Recommendations

May 13, 2024

Daily Stock Technical Recommendations

May 13, 2024

Daily Report

May 13, 2024

Daily Stock Technical Recommendations

May 8, 2024

Daily Report

May 8, 2024

Daily Stock Technical Recommendations

May 7, 2024

Daily Report

May 6, 2024

Daily Stock Technical Recommendations

May 6, 2024

Daily Stock Technical Recommendations

May 4, 2024

Daily Stock Technical Recommendations

May 3, 2024

Daily Report

May 2, 2024

Daily Stock Technical Recommendations

May 2, 2024

Daily Stock Technical Recommendations

Apr 30, 2024

Daily Report

Apr 29, 2024

Daily Stock Technical Recommendations

Apr 29, 2024

Daily Stock Technical Recommendations

Apr 26, 2024

Daily Report

Apr 26, 2024

Daily Report

Apr 25, 2024

Daily Stock Technical Recommendations

Apr 25, 2024

Daily Stock Technical Recommendations

Apr 24, 2024

Daily Report

Apr 24, 2024

Daily Stock Technical Recommendations

Apr 23, 2024

Daily Report

Apr 22, 2024

Daily Stock Technical Recommendations

Apr 22, 2024

Daily Report

Apr 19, 2024

Daily Report

Apr 18, 2024

Daily Stock Technical Recommendations

Apr 17, 2024

Daily Report

Apr 17, 2024

Daily Report

Apr 16, 2024

Daily Stock Technical Recommendations

Apr 16, 2024

Daily Stock Technical Recommendations

Apr 5, 2024

Daily Report

Apr 5, 2024

Daily Stock Technical Recommendations

Apr 4, 2024

Daily Report

Apr 4, 2024

Daily Stock Technical Recommendations

Apr 3, 2024

Daily Report

Apr 3, 2024

Daily Stock Technical Recommendations

Apr 2, 2024

Daily Report

Apr 1, 2024

Daily Stock Technical Recommendations

Apr 1, 2024

Daily Stock Technical Recommendations

Mar 28, 2024

Daily Report

Mar 28, 2024

Daily Stock Technical Recommendations

Mar 27, 2024

Daily Report

Mar 27, 2024

Daily Stock Technical Recommendations

Mar 26, 2024

Daily Stock Technical Recommendations

Mar 25, 2024

Daily Report

Mar 25, 2024

Daily Stock Technical Recommendations

Mar 22, 2024

Daily Report

Mar 22, 2024

Emiten Report

Mar 21, 2024

Daily Stock Technical Recommendations

Mar 21, 2024

Daily Report

Mar 21, 2024

Emiten Report

Mar 20, 2024

Daily Stock Technical Recommendations

Mar 20, 2024

Daily Stock Technical Recommendations

Mar 19, 2024

Daily Stock Technical Recommendations

Mar 18, 2024

Daily Report

Mar 18, 2024

Daily Stock Technical Recommendations

Mar 15, 2024

Daily Stock Technical Recommendations

Mar 14, 2024

Daily Report

Mar 14, 2024

Daily Stock Technical Recommendations

Mar 13, 2024

Daily Report

Mar 8, 2024

Daily Stock Technical Recommendations

Mar 7, 2024

Daily Report

Mar 6, 2024

Daily Stock Technical Recommendations

Mar 6, 2024

Daily Report

Mar 5, 2024

Daily Stock Technical Recommendations

Mar 5, 2024

Daily Report

Mar 4, 2024

Daily Report

Mar 1, 2024

Daily Report

Feb 29, 2024

Daily Report

Feb 28, 2024

Daily Stock Technical Recommendations

Feb 27, 2024

Daily Report

Feb 26, 2024

Daily Stock Technical Recommendations

Feb 26, 2024

Daily Stock Technical Recommendations

Feb 23, 2024

Daily Report

Feb 23, 2024

Daily Stock Technical Recommendations

Feb 22, 2024

Daily Report

Feb 22, 2024

Daily Stock Technical Recommendations

Feb 21, 2024

Daily Report

Feb 21, 2024